In fact, a recent meta-analysis found that APDs, along with α-blockers and sodium–glucose-cotransporter (SGLT)-2 inhibitors, were the most common drug classes associated with orthostatic hypotension [70]. The gene discussed is SLC5A2; the disease is hypotensive disorder.